Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations

Pavan Puligujja, Shantanu S. Balkundi, Lindsey M. Kendrick, Hannah M. Baldridge, James R. Hilaire, Aditya N. Bade, Prasanta K. Dash, Gang Zhang, Larisa Y Poluektova, Santhi Gorantla, Xin Ming Liu, Tianlei Ying, Yang Feng, Yanping Wang, Dimiter S. Dimitrov, JoEllyn M McMillan, Howard Eliot Gendelman

Research output: Contribution to journalArticle

48 Scopus citations
Original languageEnglish (US)
Pages (from-to)141-150
Number of pages10
JournalBiomaterials
Volume41
DOIs
StatePublished - Feb 1 2015

    Fingerprint

Keywords

  • Folic acid receptor
  • Human immunodeficiency virus type one
  • Long-acting nanoformulated antiretroviral therapy
  • Non-obese diabetic severe combined immunodeficient mice
  • Pharmacodynamics
  • Pharmacokinetics

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Puligujja, P., Balkundi, S. S., Kendrick, L. M., Baldridge, H. M., Hilaire, J. R., Bade, A. N., Dash, P. K., Zhang, G., Poluektova, L. Y., Gorantla, S., Liu, X. M., Ying, T., Feng, Y., Wang, Y., Dimitrov, D. S., McMillan, J. M., & Gendelman, H. E. (2015). Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations. Biomaterials, 41, 141-150. https://doi.org/10.1016/j.biomaterials.2014.11.012